(Q36181167)

12 August 2017

Therapeutic advances of new fluoroquinolones (English)

1 reference

12 August 2017

Ball P

1

1 reference

12 August 2017

Fernald A

series ordinal

2

1 reference

12 August 2017

Tillotson G

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

1 reference

12 August 2017

7

1 reference

12 August 2017

5

1 reference

12 August 2017

761-783

1 reference

Balancing the drug-resistance equation

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

An Enzyme from Bacteria able to Destroy Penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Emergence of Enterococcus as a Significant Pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Susceptibility testing of Stenotrophomonas maltophilia to carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Quinolones: structure-activity relationships and future predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Temafloxacin syndrome: review of 95 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

In vitro antibacterial activity of Q-35, a new fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

In vitro activity of the new fluoroquinolone CP-99,219.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

Pharmacokinetics of quinolones with special reference to the respiratory tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.761

21 January 2018

Identifiers

DOI

10.1517/13543784.7.5.761

1 reference

release_cyq2eofv55hjrhhk5jjqjzl56q

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cyq2eofv55hjrhhk5jjqjzl56q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference